ERNZ - ETF AI Analysis
Top Page
(undefined)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Sector Diversification
The ETF is spread across multiple sectors, including Consumer Defensive, Financials, and Industrials, which helps reduce risk from sector-specific downturns.
High U.S. Exposure
With over 94% of its holdings in U.S. companies, the ETF benefits from the stability of the U.S. market.
Steady Top Holdings
Some top holdings like CVS Health and Buckle have shown positive year-to-date performance, supporting the fund’s overall stability.
Negative Factors
High Expense Ratio
The ETF charges a significantly higher expense ratio compared to most funds, which can eat into investor returns over time.
Weak Recent Performance
The fund has experienced negative returns over the past month, three months, and year-to-date, indicating recent struggles.
Underperforming Top Holdings
Several major holdings, including Clorox, General Mills, and Apogee, have seen weak year-to-date performance, which could drag on the fund’s overall returns.
ERNZ vs. SPDR S&P 500 ETF (SPY)
AUMN/A
RegionN/A
Expense RatioN/A
BetaN/A
IssuerN/A
Inception DateN/A
Dividend YieldN/A
Asset ClassN/A
Index TrackedN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume345,903
30 Day Avg. Volume118,949
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst CoveringN/A
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ERNZ Summary
The TrueShares Active Yield ETF (ticker: ERNZ) is an actively managed fund that focuses on the total market, offering exposure to a wide range of companies across different sectors. It includes well-known names like CVS Health and Darden Restaurants, and its strategy emphasizes both growth potential and income generation. This ETF is ideal for investors seeking diversification and a balanced approach to investing in various industries, such as consumer defensive, financial, and industrial sectors. However, new investors should be aware that the fund’s high expense ratio (3.25%) could impact returns over time.
How much will it cost me?The TrueShares Active Yield ETF (ERNZ) has an expense ratio of 3.25%, meaning you’ll pay $32.50 per year for every $1,000 invested. This is higher than average because it is actively managed, requiring more resources to select investments and adjust the portfolio regularly.
What would affect this ETF?The TrueShares Active Yield ETF (ERNZ) could benefit from stable or declining interest rates, which may enhance the appeal of yield-focused investments, and positive trends in consumer spending or industrial growth could support its key sector exposures like Consumer Defensive and Industrials. However, rising interest rates or economic slowdowns could negatively impact financial and cyclical sectors, while regulatory changes or market volatility might affect its top holdings in industries like health care and energy.
ERNZ Top 10 Holdings
The TrueShares Active Yield ETF (ERNZ) leans heavily into Consumer Defensive and Financial sectors, with names like CVS Health and Buckle providing a steady lift thanks to strong earnings and reasonable valuations. However, the fund faces headwinds from lagging stocks like Clorox and Hormel Foods, which are grappling with technical weakness and profitability challenges. Energy exposure through EOG Resources has also been a drag amid declining revenue trends. With its U.S.-focused portfolio, ERNZ balances growth and income, but recent mixed performance suggests investors should keep an eye on sector-specific risks.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| CVS Health | 5.33% | $6.89M | $103.91B | 46.13% | 77 Outperform | |
| Darden Restaurants | 4.72% | $6.09M | $21.50B | 11.97% | 71 Outperform | |
| BankUnited | 4.66% | $6.02M | $2.85B | 12.02% | 67 Neutral | |
| Clorox | 4.51% | $5.82M | $14.11B | -26.53% | 62 Neutral | |
| Buckle | 4.49% | $5.80M | $2.85B | 27.60% | 81 Outperform | |
| EOG Resources | 4.40% | $5.68M | $58.08B | -12.11% | 76 Outperform | |
| General Mills | 4.22% | $5.44M | $25.29B | -29.27% | 67 Neutral | |
| Hormel Foods | 4.18% | $5.40M | $13.11B | -23.27% | 63 Neutral | |
| Apogee | 4.07% | $5.25M | $841.51M | -49.71% | 65 Neutral | |
| Lakeland Financial | 3.95% | $5.10M | $1.58B | -12.12% | 63 Neutral |
ERNZ Technical Analysis
Positive
―
Price Trends
21.37
Negative
20.89
Positive
21.16
Positive
Market Momentum
-0.02
Positive
46.02
Neutral
69.84
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ERNZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 21.43, equal to the 50-day MA of 21.37, and equal to the 200-day MA of 21.16, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 46.02 is Neutral, neither overbought nor oversold. The STOCH value of 69.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ERNZ.
ERNZ Peer Comparison
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents